Science Explorer Interactive view Map
Company · Vancouver · Canada

Kinexus Bioinformatics Corporation (Canada)

kinexus.caROR OpenAlex
Research works
39
▲ 4% vs 2013–17
Citations
1.1k
29.1 per fractional work
Top-10% rate
8.9%
record average 16.5%
Open access
38%
world 28%

Not ranked overall: Kinexus Bioinformatics Corporation (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.78× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.50× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.84× its world share, 0 worksImmunology and Micro…Neuroscience: 1.52× its world share, 0 worksNeuroscienceEnvironmental Science: 0.87× its world share, 0 worksEnvironmental ScienceMathematics: 4.73× its world share, 0 worksMathematicsMedicine: 3.02× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 4.7×. Every wedge is a field page.

Which keywords describe research at Kinexus Bioinformatics Corporation (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Glycosylation, Bioinformatics, High-Throughput Analysis, Protein Microarrays, Fc Receptors, Therapeutic Antibodies and Mutation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Cancer Therapy4▲ 17×8 topics
  2. Glycosylation4▲ 41×3 topics
  3. Machine Learning3▲ 3.3×5 topics
  4. Oxidative Stress3▲ 3.6×8 topics
  5. Bioinformatics2▲ 51×3 topics
  6. Cancer2▲ 4.2×10 topics
  7. Fc Receptors2▲ 56×1 topic
  8. High-Throughput Analysis2▲ 123×1 topic
  9. Protein Microarrays2▲ 284×1 topic
  10. Therapeutic Antibodies2▲ 44×1 topic
  11. Mutation2▲ 32×4 topics
  12. Protein-Protein Interactions2▲ 44×3 topics
  13. Apoptosis2▲ 12×4 topics
  14. Epidemiology2◆ 1.10×13 topics
  15. Gene Expression2▲ 6.6×4 topics
  16. Inflammation2▲ 1.78×10 topics
  17. Neurodegeneration2▲ 13×5 topics
  18. Immune Response2▲ 6.0×6 topics
  19. Mass Spectrometry1▲ 17×3 topics
  20. Proteomics1▲ 30×2 topics
  21. Data Analysis1▲ 10×2 topics
  22. Innate Immunity1▲ 9.5×5 topics
  23. Microarray1▲ 111×1 topic
  24. Mitochondrial Dysfunction1▲ 9.1×4 topics
  25. Normalization1▲ 45×1 topic
  26. Self-Assembly1▲ 8.6×3 topics
  27. Drug Discovery1▲ 7.4×1 topic
  28. Oncogenic Mutations1▲ 66×2 topics
  29. Peptide Synthesis1▲ 37×1 topic
  30. Regulation1▲ 5.0×3 topics
  31. Tumor Suppression1▲ 26×2 topics
  32. Cell Division1▲ 76×1 topic
  33. Microtubules1▲ 76×1 topic
  34. Protein Identification1▲ 120×1 topic
  35. Quantitative Analysis1▲ 17×1 topic
  36. Cell Cycle1▲ 45×1 topic
  37. Environmental Monitoring1▲ 8.0×2 topics
  38. p531▲ 60×1 topic

Which research topics does Kinexus Bioinformatics Corporation (Canada) publish most on?

By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, COVID-19 epidemiological studies and Advanced Biosensing Techniques and Applications.

SARS-CoV-2 and COVID-19 Research: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksCOVID-19 epidemiological studies: 0 fractional worksAdvanced Biosensing Techniques and Applications: 0 fractional worksPneumonia and Respiratory Infections: 0 fractional worksInfluenza Virus Research Studies: 0 fractional worksAnimal Virus Infections …0Animal Virus Infections Studies: 0 fractional worksHepatitis B Virus Studies: 0 fractional worksAlzheimer's disease research and treatments: 0 fractional worksGene expression and canc…0Gene expression and cancer classification: 0 fractional works
Infectious DiseasesRadiology, Nuclear Medicine and ImagingModeling and SimulationMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 COVID-19 epidemiological studies Modeling and Simulation 0 works
  4. 4 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  5. 5 Pneumonia and Respiratory Infections Epidemiology 0 works
  6. 6 Influenza Virus Research Studies Epidemiology 0 works
  7. 7 Animal Virus Infections Studies Animal Science and Zoology 0 works
  8. 8 Hepatitis B Virus Studies Epidemiology 0 works
  9. 9 Alzheimer's disease research and treatments Physiology 0 works
  10. 10 Gene expression and cancer classification Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.5%not open62.5%

World: 28% of research is openly available.

with international co-authors31.8%domestic only68.2%

World: 19% is written across borders.

How has Kinexus Bioinformatics Corporation (Canada)'s research output changed?

Output in 2018–2022 was 4% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vancouver

All research institutions in Vancouver

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.